Literature DB >> 28318900

Epidemiological and mycological characteristics of candidemia in Iran: A systematic review and meta-analysis.

A Vaezi1, H Fakhim2, S Khodavaisy3, A Alizadeh4, M Nazeri5, A Soleimani6, T Boekhout7, H Badali8.   

Abstract

To date, there has been no comprehensive review of the epidemiology, risk factors, species distribution, and outcomes of candidemia in Iran. This study aimed to perform a systematic review and meta-analysis of all reported candidemia cases in Iran until December 2015. The review process occurred in three steps, namely a literature search, data extraction and statistical analyses. After a comprehensive literature search, we identified 55 cases. The mean age of patients was 46.80±24.30 years (range 1-81 years). The main risk factors for candidemia were surgery and burns (23.6%), followed by malignancies (20%), use of broad-spectrum antibiotics (18.2%), and diabetes (7.3%). Candida parapsilosis (n=17, 30.8%) was the leading agent, followed by Candida albicans (n=15, 27.3%), Candida glabrata (n=10, 18.2%), and Candida tropicalis (n=8, 14.5%). The frequencies of candidemia cases due to C. glabrata, C. parapsilosis, and C. albicans were significantly higher among patients aged>60, 21-40, and 41-60 years, respectively. Comparison of risk factors for candidemia by multiple logistic regression showed that one of the most important risk factors was surgery (OR: 4.245; 95% CI: 1.141-15.789; P=0.031). The outcome was recorded in only 19 cases and 13 of those patients (68.4%) expired. This study confirms that knowledge of the local epidemiology is important when conducting surveillance studies to prevent and control candidemia and will be of interest for antifungal stewardship.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Candida sp.; Candida species; Candidemia; Candidémie; Epidemiology; Facteurs de risque; Iran; Meta-analysis; Méta-analyse; Risk factors; Épidémiologie

Mesh:

Year:  2017        PMID: 28318900     DOI: 10.1016/j.mycmed.2017.02.007

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  17 in total

1.  Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience).

Authors:  Bilgul Mete; Esra Yerlikaya Zerdali; Gokhan Aygun; Nese Saltoglu; Ilker Inanc Balkan; Ridvan Karaali; Sibel Yildiz Kaya; Berna Karaismailoglu; Abdurrahman Kaya; Seval Urkmez; Gunay Can; Fehmi Tabak; Recep Ozturk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-09-15       Impact factor: 3.267

2.  Candidemia due to Candida guilliermondii in an immuno-compromised infant: a case report and review of literature.

Authors:  Fatemeh Ahangarkani; Hamid Badali; Mohammad Sadegh Rezai; Tahereh Shokohi; Zahra Abtahian; Hassan Mahmoodi Nesheli; Hossein Karami; Emmanuel Roilides; Ahmad Tamaddoni
Journal:  Curr Med Mycol       Date:  2019-03

3.  Evaluation of a new matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for the identification of yeast isolation.

Authors:  Hyeyoung Lee; Ji-Hyun Park; Junsang Oh; Sungil Cho; Jehyun Koo; Ik Chun Park; Jiwoo Kim; Sehyun Park; Ji Seon Choi; So Youn Shin; Gi-Ho Sung; Jayoung Kim
Journal:  J Clin Lab Anal       Date:  2018-10-08       Impact factor: 2.352

4.  Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.

Authors:  Narges Aslani; Ghasem Janbabaei; Mahdi Abastabar; Jacques F Meis; Mahasti Babaeian; Sadegh Khodavaisy; Teun Boekhout; Hamid Badali
Journal:  BMC Infect Dis       Date:  2018-01-08       Impact factor: 3.090

5.  Effect of biogenic selenium nanoparticles on ERG11 and CDR1 gene expression in both fluconazole-resistant and -susceptible Candida albicans isolates.

Authors:  Nasrin Parsameher; Sassan Rezaei; Sadegh Khodavasiy; Samira Salari; Sanaz Hadizade; Mohammad Kord; Seyed Amin Ayatollahi Mousavi
Journal:  Curr Med Mycol       Date:  2017-09

Review 6.  Targeting the Immune System with Plant Lectins to Combat Microbial Infections.

Authors:  Jannyson J B Jandú; Roberval N Moraes Neto; Adrielle Zagmignan; Eduardo M de Sousa; Maria C A Brelaz-de-Castro; Maria T Dos Santos Correia; Luís C N da Silva
Journal:  Front Pharmacol       Date:  2017-10-04       Impact factor: 5.810

Review 7.  Update on invasive fungal infections in the Middle Eastern and North African region.

Authors:  Marwan Osman; Aisha Al Bikai; Rayane Rafei; Hassan Mallat; Fouad Dabboussi; Monzer Hamze
Journal:  Braz J Microbiol       Date:  2020-07-05       Impact factor: 2.476

8.  Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait.

Authors:  Ziauddin Khan; Suhail Ahmad; Noura Al-Sweih; Eiman Mokaddas; Khalifa Al-Banwan; Wadha Alfouzan; Inaam Al-Obaid; Khaled Al-Obaid; Mohammad Asadzadeh; Ahlam Jeragh; Leena Joseph; Soumya Varghese; Sandhya Vayalil; Omar Al-Musallam
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

9.  Isolation, characterization, and molecular identification of Candida species from urinary tract infections.

Authors:  Amin Gharanfoli; Elaheh Mahmoudi; Roya Torabizadeh; Farzad Katiraee; Saeid Faraji
Journal:  Curr Med Mycol       Date:  2019-06

10.  Butenafine and analogues: An expeditious synthesis and cytotoxicity and antifungal activities.

Authors:  Ana María Garzón Porras; Bruna Silva Terra; Taniris Cafiero Braga; Thais Furtado Ferreira Magalhães; Cleide Viviane Buzanello Martins; Danielle Letícia da Silva; Ludmila Matos Baltazar; Ludmila Ferreira Gouveia; Gustavo José Cota de Freitas; Daniel Assis Santos; Maria Aparecida Resende-Stoianoff; Beth Burgwyn Fuchs; Eleftherios Mylonakis; Rossimiriam Pereira de Freitas; Ângelo de Fátima
Journal:  J Adv Res       Date:  2018-06-21       Impact factor: 10.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.